Literature DB >> 26575885

[Disease spectrum and causes of death in hospitalized children in an upper first-class hospital in Hunan Province, China, from 2010 to 2014].

Jin-Biao Chen1, Li Zhao, Jing Zhang, Wei-Qiang Zhou, Min Jin.   

Abstract

OBJECTIVE: To study the disease spectrum and causes of death in hospitalized children in an upper first-class hospital in Hunan Province, China.
METHODS: The medical records of hospitalized children between 2010 and 2014 in this hospital were collected and analyzed retrospectively.
RESULTS: From 2010 to 2014, the number of hospitalized children increased from 7 303 in 2010 to 10 902 in 2014, and the case fatality rate declined from 0.33% to 0.20% (P<0.05). The case fatality rate was highest (0.41%) in infants and lowest (0.11%) in newborns. As for the disease spectrum for these hospitalized children, in 2010, the top three diseases were leukemia, congenital heart disease, and pneumonia; in 2011, the top three diseases were tumor chemotherapy, congenital heart disease, and pneumonia; since 2012, tumor chemotherapy, epilepsy, and pneumonia had remained the top three diseases. The top three causes of death in hospitalized children were congenital malformation (39%, 39/99), tumor (13%, 13/99), and infectious diseases/parasitic diseases (8%, 8/99).
CONCLUSIONS: The number of hospitalized children is increasing, while the case fatality rate tends to decrease in this hospital. Tumor, epilepsy, pneumonia, and congenital heart disease are major diseases in hospitalized children, and congenital malformation is the primary cause of death.

Entities:  

Mesh:

Year:  2015        PMID: 26575885

Source DB:  PubMed          Journal:  Zhongguo Dang Dai Er Ke Za Zhi        ISSN: 1008-8830


  1 in total

1.  Disease spectrum analysis of hospitalized children in China: A study of 18 tertiary children's hospitals.

Authors:  Guoshuang Feng; Yueping Zeng; Jian Tian; Xinyu Wang; Jun Tai; Fei Song; Xin Zhang; Xin Xu; Jun Chen; Tieliu Shi; Xin Ni
Journal:  Pediatr Investig       Date:  2019-09-26
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.